Value, Access & Pricing
Demonstrate Value. Secure Access. Price With Confidence.
Rising evidence expectations, evolving access policies, and pricing pressures are reshaping the path to commercial success. Trinity helps life sciences leaders align Value, Access and Pricing (VAP) strategies to navigate trade-offs and realize commercial potential.
The Challenge
Differentiation Is Difficult to Prove
Payers and health systems are scrutinizing comparators, endpoints, populations, and trial design more closely. Evidence choices made early determine which value claims remain credible at launch, which patients can be reimbursed, and how effectively that value can be communicated to the distinct audiences shaping access and pricing decisions.
Access Pathways Are Fragmented
Public, private, hospital, pharmacy, self-pay, and patient-directed channels impose different requirements. Coverage and reimbursement alone may not drive uptake when provider economics, capacity, distribution, affordability, or patient navigation remain unresolved. Companies need distinct but coordinated strategies for the channels that matter most.
Pricing Pressure Is Compounding
Global reference dynamics increasingly expose list-price decisions across markets, while rebates, gross-to-net pressure, affordability, and channel economics erode local margins. Leaders must make explicit trade-offs across price, contracting, restrictions, patient reach, launch sequence, and long-term portfolio value.
Policy Change Is Accelerating
High-impact reforms are advancing across markets and interacting in ways that can quickly date existing assumptions. Positioning and investment decisions made today must anticipate the evidence expectations, pricing dynamics, and access conditions likely to shape the market tomorrow, even before final policy outcomes or cross-market implications are fully known.
The Solution
Make Confident Value, Access & Pricing Decisions with Trinity
Value, Access & Pricing
Align evidence, access, and pricing decisions to support commercial potential.
What Value, Access & Pricing Solves
Trinity helps companies optimize value, access and pricing across the product lifecycle to realize full commercial potential.
- Value strategy: Develop a differentiated value proposition and evidence strategy that addresses stakeholder requirements, patient needs, and commercial ambition.
- Access strategy: Determine where and how to secure access across stakeholders, channels, and markets.
- Access analytics and contracting: Use payer insights and analytics to design contracting approaches that balance coverage, economics, and strategic flexibility.
- Pricing strategy: Establish defensible price potential and explicit trade-offs across access breadth, restrictions, margins, and patient reach.
The Impact
Trinity has supported over 600 assets, including over 35% of annual FDA launches, for more than 320 clients, bringing deep experience to value, access, and pricing decisions.
How We Help
Trinity brings together Value, Access & Pricing strategy, analytics, market-level expertise, and technology to address the specific decisions at hand.
Global Expertise
Global strategy is grounded in local geographic SMEs who understand each market’s systems, stakeholders, policies, and negotiations.
TrinityEDGE™ Technology
Trinity technologies help teams assess payer evidence requirements, test key assumptions, and explore implications for value, access and pricing strategies.
Specialized Teams and Advisory Services
Trinity combines evidence, value, access, pricing, analytics, and technology with global and local expertise to deliver rigorous, actionable strategies grounded in market-level realities.
Trinity combines evidence, value, access, pricing, analytics, and technology with global and local expertise to deliver rigorous, actionable strategies that account for evidence, access, pricing, and market-level realities.
What Makes Trinity Different
Integrated Value, Access & Pricing Expertise
Value, access analytics, contracting, and pricing specialists work together around the same strategic decision, not as disconnected capabilities.
Global Reach, Local Fluency
Global strategy is grounded in geographic SMEs with deep knowledge of local health systems, stakeholders, policy, channels, and negotiation realities.
Diagnosis Before Solution
Stakeholder insight and analytics identify whether evidence gaps, policy, contracting, provider behavior, affordability, channels, or patient journey barriers are limiting performance.
Connected to Commercialization
VAP implications are connected to development, medical, regulatory, forecasting, launch, lifecycle, and broader commercial decisions.
Latest Resources
Get Started
Make Value, Access & Pricing Decisions with Greater Clarity
Bring your value, access & pricing ambitions into one strategy. Trinity can help you navigate complexity, clarify the trade-offs that matter, and build a coordinated strategy for evidence, access, and pricing.